ORITAVANCIN DIPHOSPHATE for Osteomyelitis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where ORITAVANCIN DIPHOSPHATE was used for Osteomyelitis.
Most Reported Side Effects for ORITAVANCIN DIPHOSPHATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple use of single-use product | 102 | 37.0% | 1 | 13 |
| Chills | 87 | 31.5% | 0 | 10 |
| Infusion related reaction | 63 | 22.8% | 0 | 8 |
| Off label use | 49 | 17.8% | 0 | 8 |
| Back pain | 41 | 14.9% | 0 | 5 |
| Pruritus | 36 | 13.0% | 0 | 1 |
| Dyspnoea | 35 | 12.7% | 0 | 6 |
| Flushing | 35 | 12.7% | 0 | 0 |
| Tremor | 35 | 12.7% | 0 | 6 |
| Nausea | 33 | 12.0% | 1 | 3 |
| Rash | 25 | 9.1% | 0 | 0 |
| Vomiting | 22 | 8.0% | 0 | 2 |
| Chest pain | 21 | 7.6% | 0 | 5 |
| Erythema | 17 | 6.2% | 0 | 0 |
| Feeling cold | 15 | 5.4% | 0 | 2 |
Other Indications for ORITAVANCIN DIPHOSPHATE
Product used for unknown indication (159)
Cellulitis (45)
Staphylococcal infection (8)
Device related infection (7)
Other Drugs Used for Osteomyelitis
VANCOMYCIN (980)
DAPTOMYCIN (635)
LINEZOLID (369)
PIPERACILLIN\TAZOBACTAM (292)
CLINDAMYCIN (223)
LEVOFLOXACIN (198)
CEFEPIME (186)
METRONIDAZOLE (183)
CEFTRIAXONE (181)
ERTAPENEM (176)